Susquehanna International Group
ANIP icon

Susquehanna International Group’s ANI Pharmaceuticals ANIP Stock Holding History

Susquehanna International Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$823K Sell
10,700
-400
-4% -$31.2K ﹤0.01% 8407
2025
Q4 		$876K Sell
11,100
-7,100
-39% -$615K ﹤0.01% 7485
2025
Q3 		$1.67M Buy
18,200
+13,000
+250% +$1.06M ﹤0.01% 6176
2025
Q2 		$339K Buy
5,200
+1,400
+37% +$91.2K ﹤0.01% 10066
2025
Q1 		$254K Buy
+3,800
New +$227K ﹤0.01% 10434
2024
Q4 		– Sell
-3,500
Closed -$209K – 12119
2024
Q3 		$209K Buy
+3,500
New +$214K ﹤0.01% 10381
2024
Q2 		– Sell
-226,400
Closed -$15.7M – 11967
2024
Q1 		$15.7M Buy
+226,400
New +$13.7M ﹤0.01% 2058
2023
Q4 		– Sell
-17,200
Closed -$999K – 12292
2023
Q3 		$999K Buy
17,200
+3,900
+29% +$225K ﹤0.01% 6637
2023
Q2 		$716K Buy
13,300
+1,600
+14% +$70.9K ﹤0.01% 7465
2023
Q1 		$465K Sell
11,700
-1,700
-13% -$71.7K ﹤0.01% 8738
2022
Q4 		$539K Sell
13,400
-39,800
-75% -$1.49M ﹤0.01% 7658
2022
Q3 		$1.71M Hold
53,200
– – ﹤0.01% 5267
2022
Q2 		$1.58M Buy
53,200
+1,400
+3% +$40.4K ﹤0.01% 5405
2022
Q1 		$1.46M Buy
51,800
+10,400
+25% +$388K ﹤0.01% 6213
2021
Q4 		$1.91M Buy
41,400
+22,800
+123% +$980K ﹤0.01% 5620
2021
Q3 		$610K Buy
18,600
+4,800
+35% +$149K ﹤0.01% 8877
2021
Q2 		$484K Buy
13,800
+3,300
+31% +$112K ﹤0.01% 9672
2021
Q1 		$379K Sell
10,500
-8,700
-45% -$272K ﹤0.01% 10100
2020
Q4 		$558K Sell
19,200
-3,300
-15% -$94.5K ﹤0.01% 8038
2020
Q3 		$635K Sell
22,500
-35,300
-61% -$1.05M ﹤0.01% 7162
2020
Q2 		$1.87M Buy
57,800
+44,700
+341% +$1.6M ﹤0.01% 4622
2020
Q1 		$534K Sell
13,100
-19,800
-60% -$1.05M ﹤0.01% 6801
2019
Q4 		$2.03M Sell
32,900
-35,200
-52% -$2.33M ﹤0.01% 4307
2019
Q3 		$4.96M Buy
68,100
+17,300
+34% +$1.29M ﹤0.01% 2739
2019
Q2 		$4.18M Buy
50,800
+26,600
+110% +$1.89M ﹤0.01% 2959
2019
Q1 		$1.71M Buy
24,200
+10,700
+79% +$630K ﹤0.01% 4008
2018
Q4 		$608K Sell
13,500
-2,700
-17% -$142K ﹤0.01% 5665
2018
Q3 		$916K Sell
16,200
-15,200
-48% -$930K ﹤0.01% 5394
2018
Q2 		$2.1M Sell
31,400
-53,600
-63% -$3.35M ﹤0.01% 3942
2018
Q1 		$4.95M Buy
85,000
+22,500
+36% +$1.43M ﹤0.01% 2549
2017
Q4 		$4.03M Sell
62,500
-500
-0.8% -$31.1K ﹤0.01% 2818
2017
Q3 		$3.31M Buy
63,000
+14,900
+31% +$710K ﹤0.01% 3079
2017
Q2 		$2.25M Sell
48,100
-61,700
-56% -$2.98M ﹤0.01% 3712
2017
Q1 		$5.44M Buy
109,800
+43,600
+66% +$2.45M ﹤0.01% 2273
2016
Q4 		$4.01M Sell
66,200
-39,900
-38% -$2.44M ﹤0.01% 2783
2016
Q3 		$7.04M Sell
106,100
-1,400
-1% -$87.6K ﹤0.01% 1852
2016
Q2 		$6M Sell
107,500
-64,200
-37% -$3.12M ﹤0.01% 1983
2016
Q1 		$5.78M Sell
171,700
-34,500
-17% -$1.17M ﹤0.01% 2123
2015
Q4 		$9.3M Buy
206,200
+128,200
+164% +$5.52M ﹤0.01% 1821
2015
Q3 		$3.08M Buy
78,000
+14,900
+24% +$848K ﹤0.01% 3454
2015
Q2 		$3.92M Buy
63,100
+45,100
+251% +$2.68M ﹤0.01% 3356
2015
Q1 		$1.13M Buy
+18,000
New +$1.09M ﹤0.01% 5508
2014
Q1 		– Sell
-42,500
Closed -$853K – 8849
2013
Q4 		$853K Sell
42,500
-2,100
-5% -$27.2K ﹤0.01% 5773
2013
Q3 		$436K Buy
44,600
+37,167
+500% +$268K ﹤0.01% 6632
2013
Q2 		$45K Buy
+7,433
New +$52K ﹤0.01% 7992

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group's ANIP Position: Q1 2026 in Review

Susquehanna International Group increased its ANI Pharmaceuticals (ANIP) stake by 348% in Q1 2026, buying an estimated $3.28M and bringing the position to 54,114 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #4587.

Susquehanna International Group first reported a position in ANIP in Q1 2014 and has held it in 39 quarters since. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Susquehanna International Group held 54,114 shares of ANI Pharmaceuticals worth $4.16M as of Q1 2026.
  • Susquehanna International Group bought 42,047 ANI Pharmaceuticals shares in Q1 2026, an estimated $3.28M.
  • ANI Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4587 holding.
  • Susquehanna International Group first reported a position in ANI Pharmaceuticals in Q1 2014 and has held it in 39 quarters since.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.